Oxford Biomedical Technologies is recruiting participants for a new clinical research study to determine the levels of inflammatory blood markers in individuals with and without inflammatory bowel disease (IBD) [Crohn’s disease (CD) and ulcerative colitis (UC)]. This study may play an essential role in advancing clinical care for IBD individuals, leading to improvements in health, quality of life, and reduced healthcare costs.
Research activities include:
- 1 in-person study visit
- Blood collection
- Physical measurements (weight, height, waist circumference)
- Assessment of symptoms and quality of life with written study questionnaires
Participants will receive the following:
$150 for individuals with IBD
- $75 for individuals without IBD
To determine eligibility for the study, please fill out the following form. A member of our research team will contact you to discuss participation. All personal information will be kept confidential and follow strict HIPAA guidelines.